109164-85-4

Upstream product

• 124268-74-2 6-<(2E)-4-chloro-3-methylbut-2-enyl>-2,5-diketo-4-(4-methoxybenzyl)-1,4-diazabicyclo<4.3.0>nonane 
• 2393-23-9 4-methoxy-benzylamine 
• 124268-74-2 8a-((E)-4-Chloro-3-methyl-but-2-enyl)-2-(4-methoxy-benzyl)-hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione 
• 109164-76-3 [[2-Benzyloxycarbonylamino-4-(tert-butyl-dimethyl-silanyloxy)-butyryl]-(4-methoxy-benzyl)-amino]-acetic acid ethyl ester 
• 109164-79-6 8a-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-(4-methoxy-benzyl)-hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione 
• 109164-78-5 4-(3-Bromo-propyl)-3-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-1-(4-methoxy-benzyl)-piperazine-2,5-dione 
• 109164-86-5 8a-((E)-4-Hydroxy-3-methyl-but-2-enyl)-2-(4-methoxy-benzyl)-hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione 
• 109164-84-3 (E)-4-[2-(4-Methoxy-benzyl)-1,4-dioxo-hexahydro-pyrrolo[1,2-a]pyrazin-8a-yl]-2-methyl-but-2-enal 
• 109164-81-0 [2-(4-Methoxy-benzyl)-1,4-dioxo-hexahydro-pyrrolo[1,2-a]pyrazin-8a-yl]-acetaldehyde 
• 109164-77-4 3-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-1-(4-methoxy-benzyl)-piperazine-2,5-dione 
• 109164-80-9 8a-(2-Hydroxy-ethyl)-2-(4-methoxy-benzyl)-hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione 
• 109392-77-0 2-Benzyloxycarbonylamino-4-(tert-butyl-dimethyl-silanyloxy)-butyric acid 
• 60857-16-1 N-(4-methoxybenzyl)glycine ethyl ester 
• 79074-03-6 2-(benzyloxycarbonylamino)-4-hydroxybutanoic acid 

Downstream Products

• 124316-31-0 2,8-diketo-9-<1-(4-methoxyphenyl)-2-phenylethyl>-10-(1-methylethenyl)-3,9-diazatricyclo<5.2.2.0^3,7>undecane 
• 124375-85-5 2,8-diketo-9-(4-methoxybenzyl)-10-(1-methylethenyl)-1-benzyl-3,9-diazatricyclo<5.2.2.0^3,7>undecane 
• 109164-83-2 (S)-2-[(1R,7R,11S)-8-(4-Methoxy-benzyl)-6,9-dioxo-5,8-diaza-tricyclo[5.2.2.0^1,5]undec-11-yl]-propionic acid ethyl ester 
• 109164-83-2 (R)-2-[(1R,7R,11S)-8-(4-Methoxy-benzyl)-6,9-dioxo-5,8-diaza-tricyclo[5.2.2.0^1,5]undec-11-yl]-propionic acid ethyl ester 

Relevant academic research and scientific papers

Asymmetric, stereocontrolled total synthesis of (-)-brevianamide B

The asymmetric, stereocontrolled total synthesis of (-)-brevianamide B (2) is described. The synthesis features a stereocontrolled intramolecular SN2′ cyclization to construct the central bicyclo[2.2.2] nucleus. A synthetic route to C-10-epibre

PROMISING CYCLIZATION REACTIONS TO CONSTRUCT THE RING SYSTEMS OF BREVIANAMIDES A,B

An effective intramolecular Michael cyclization and intramolecular SN2'cyclization is described for constructing the tricyclic framework of the natural mycotoxins brevianamides A,B.